News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Carroll Jill
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Carroll Jill (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Granted 11,459 options to buy
@ $37.94, valued at
$434.8k
|
|
| 06/02/2023 |
4
| Carroll Jill (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 315,164 shares
@ $41.5, valued at
$13.1M
Sold 25,556 shares
@ $44.3464, valued at
$1.1M
|
|
| 05/15/2023 |
4
| Carroll Jill (Director) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 631,932 shares
@ $45, valued at
$28.4M
Sold 6,485 shares
@ $46.15, valued at
$299.3k
|
|
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Carroll Jill (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Unknown transaction of 5,674,221 shares
@ $60, valued at
$340.5M
Disposed/sold 13,997 options to buy
@ $18, valued at
$251.9k
|
|
| 07/21/2020 |
4
| Carroll Jill (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 1,538,724 shares
@ $0
Converted 348,469 shares
@ $0
Bought 361,111 shares
@ $18, valued at
$6.5M
Converted 7,846,554 preferred shares
@ $0
Converted 1,776,980 preferred shares
@ $0
Granted 13,997 options to buy
@ $18, valued at
$251.9k
|
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|